Phic31 Integration

PhiC31 integrase recognizes two different recombination sites: attB on donor DNA and attP in the target genome. It joins these substrates and converts the original sites into attL and attR junctions. Tracking those junctions provides a molecular signature that the donor and host DNA have undergone the intended recombination event rather than remaining separate.

Unlike homology-dependent insertion, this strategy does not require extended sequence matching between the donor and host. The essential sequence relationship is recognition of attB and attP by the integrase. That distinction makes the method useful when a researcher needs stable genetic insertion but does not have a precisely homologous genomic target sequence available.

In many animal cells, the genomic partner is a pseudo-attP site rather than a deliberately engineered attP locus. The host genome therefore supplies the integration context, while the donor still needs the attB recognition site. This feature distinguishes the system from approaches that depend on constructing matching homology regions for a predetermined recombination event.

A basic design begins by placing the genetic material of interest next to an attB site on donor DNA and identifying the attP or pseudo-attP partner in the host genome. PhiC31 integrase then provides the recombination activity that joins donor and genomic DNA. This arrangement is central to building stable transgenic cell or organism systems.

Evidence of the intended event can be tied to the attL-attR junctions created after recombination. Researchers can also consider whether the inserted sequence supports stable transgene expression, since long-term expression is a major outcome of the system. Together, junction formation and durable expression connect the DNA-level event with its functional value in a biological model.

Phic31 Integration is useful for creating transgenic cells and organisms when experiments require genetic material to remain in the host genome. In biology research, those systems support gene-function studies, disease modeling, and experimental systems for long-term genetic manipulation. The method therefore serves both to establish a model and to observe consequences of persistent transgene expression.